HLCS
Biotin--protein ligase
Also known as: BPL1_HUMAN, HCS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50747
- Gene
- HLCS
- Ensembl
- ENSG00000159267
- Chromosome
- 21
- Canonical length
- 726 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the binding of biotin to carboxylases and histones. The protein plays an important role in gluconeogenesis, fatty acid synthesis and branched chain amino acid catabolism. Defects in this gene are the cause of holocarboxylase synthetase deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
726 residues, UniProt reviewed canonical sequence.
>P50747|HLCS
1 MEDRLHMDNG LVPQKIVSVH LQDSTLKEVK DQVSNKQAQI LEPKPEPSLE IKPEQDGMEH
61 VGRDDPKALG EEPKQRRGSA SGSEPAGDSD RGGGPVEHYH LHLSSCHECL ELENSTIESV
121 KFASAENIPD LPYDYSSSLE SVADETSPER EGRRVNLTGK APNILLYVGS DSQEALGRFH
181 EVRSVLADCV DIDSYILYHL LEDSALRDPW TDNCLLLVIA TRESIPEDLY QKFMAYLSQG
241 GKVLGLSSSF TFGGFQVTSK GALHKTVQNL VFSKADQSEV KLSVLSSGCR YQEGPVRLSP
301 GRLQGHLENE DKDRMIVHVP FGTRGGEAVL CQVHLELPPS SNIVQTPEDF NLLKSSNFRR
361 YEVLREILTT LGLSCDMKQV PALTPLYLLS AAEEIRDPLM QWLGKHVDSE GEIKSGQLSL
421 RFVSSYVSEV EITPSCIPVV TNMEAFSSEH FNLEIYRQNL QTKQLGKVIL FAEVTPTTMR
481 LLDGLMFQTP QEMGLIVIAA RQTEGKGRGG NVWLSPVGCA LSTLLISIPL RSQLGQRIPF
541 VQHLMSVAVV EAVRSIPEYQ DINLRVKWPN DIYYSDLMKI GGVLVNSTLM GETFYILIGC
601 GFNVTNSNPT ICINDLITEY NKQHKAELKP LRADYLIARV VTVLEKLIKE FQDKGPNSVL
661 PLYYRYWVHS GQQVHLGSAE GPKVSIVGLD DSGFLQVHQE GGEVVTVHPD GNSFDMLRNL
721 ILPKRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLCS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- kidney: 13 nTPM
- skeletal muscle: 13 nTPM
- thyroid gland: 10 nTPM
- liver: 9.9 nTPM
- parathyroid gland: 9.9 nTPM
- prostate: 8.4 nTPM
Single-cell type
- retinal pigment epithelial cells: 571 nCPM
- thyrotrophs: 516 nCPM
- gonadotrophs: 470 nCPM
- lactotrophs: 411 nCPM
- somatotrophs: 397 nCPM
- myonuclei: 287 nCPM
Immune cell
- non-classical monocyte: 5.2 nTPM
- NK-cell: 4.8 nTPM
- gdT-cell: 3.6 nTPM
- MAIT T-cell: 2.9 nTPM
- naive CD4 T-cell: 2.4 nTPM
- memory CD8 T-cell: 2.3 nTPM
Brain region
- choroid plexus: 31 nTPM
- cerebellum: 29 nTPM
- hippocampal formation: 24 nTPM
- pons: 24 nTPM
- cerebral cortex: 23 nTPM
- hypothalamus: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HLCS.
Disease | AllUniProt
Conditions HLCS is implicated in, by any mechanism.
- Holocarboxylase synthetase deficiency (HLCS deficiency) MIM:253270
Disease | GeneticClinVar
194 pathogenic / likely-pathogenic of 1,117 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Holocarboxylase synthetase deficiency
- Inborn genetic diseases
- Ovarian serous cystadenocarcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- biotin binding
- enzyme binding
- identical protein binding
- biotin--[biotin carboxyl-carrier protein] ligase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain
- Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)
- Biotin protein ligase, C-terminal
- Biotin--acetyl-CoA-carboxylase ligase
- Biotin protein ligase C terminal domain
- Biotin/lipoate A/B protein ligase family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HLCS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLCS as an antibody target. Whether an autoantibody or antibody against HLCS could matter depends on whether native HLCS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLCS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HLCS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...